Cargando…

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study

BACKGROUND: Routine annual influenza vaccination is primarily recommended for all persons aged 60 and above and for people with underlying chronic conditions in Germany. Other countries have already adopted additional childhood influenza immunisation programmes. The objective of this study is to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rose, Markus A, Damm, Oliver, Greiner, Wolfgang, Knuf, Markus, Wutzler, Peter, Liese, Johannes G, Krüger, Hagen, Wahn, Ulrich, Schaberg, Tom, Schwehm, Markus, Kochmann, Thomas F, Eichner, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905925/ https://www.ncbi.nlm.nih.gov/pubmed/24450996 http://dx.doi.org/10.1186/1471-2334-14-40

Ejemplares similares

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
por: Damm, Oliver, et al.
Publicado: (2014)

4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
por: Eichner, Martin, et al.
Publicado: (2014)

Direct and indirect effects of influenza vaccination
por: Eichner, Martin, et al.
Publicado: (2017)

Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations
por: Schmidt-Ott, Ruprecht, et al.
Publicado: (2019)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
por: Dolk, Christiaan, et al.
Publicado: (2016)

Influence of social contact patterns and demographic factors on influenza simulation results
por: Schmidt-Ott, Ruprecht, et al.
Publicado: (2016)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

The influenza pandemic preparedness planning tool InfluSim
por: Eichner, Martin, et al.
Publicado: (2007)

Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
por: Gerlier, Laetitia, et al.
Publicado: (2017)

Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure
por: Eichner, Martin, et al.
Publicado: (2009)

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany
por: Molnar, Daniel, et al.
Publicado: (2022)

Finding and removing highly connected individuals using suboptimal vaccines
por: Vidondo, Beatriz, et al.
Publicado: (2012)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions
por: Duerr, Hans P, et al.
Publicado: (2007)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Modeling the effects of drug resistant influenza virus in a pandemic
por: Brockmann, Stefan O, et al.
Publicado: (2008)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Antiviral prophylaxis during pandemic influenza may increase drug resistance
por: Eichner, Martin, et al.
Publicado: (2009)

The burden of seasonal and pandemic influenza in infants and children
por: Ruf, Bernhard R., et al.
Publicado: (2013)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013
por: Haas, Jennifer, et al.
Publicado: (2015)

Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis
por: Damm, Oliver, et al.
Publicado: (2022)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
por: Scholz, Stefan, et al.
Publicado: (2019)

Efficacy of Influenza Vaccination and Tamiflu® Treatment – Comparative Studies with Eurasian Swine Influenza Viruses in Pigs
por: Duerrwald, Ralf, et al.
Publicado: (2013)

Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
por: Böhmer, Merle M, et al.
Publicado: (2012)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

The uptake of influenza vaccination for the 2013/2014 season in Germany
por: Poethko-Müller, Christina, et al.
Publicado: (2017)

Local measles vaccination gaps in Germany and the role of vaccination providers
por: Eichner, Linda, et al.
Publicado: (2017)

1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children
por: Lindsey, Benjamin, et al.
Publicado: (2018)

The COVID-19 pandemic preparedness simulation tool: CovidSIM
por: Schneider, Kristan A., et al.
Publicado: (2020)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

Cross-Sectional Study on Influenza Vaccination, Germany, 1999–2000
por: Rehmet, Sybille, et al.
Publicado: (2002)

The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany
por: Kohli, Michele A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnh7ah3dmnon2tj2b7ishqsuag